Literature DB >> 27160973

Periplocin Extracted from Cortex Periplocae Induced Apoptosis of Gastric Cancer Cells via the ERK1/2-EGR1 Pathway.

Lei Li, Lian-Mei Zhao, Su-Li Dai, Wen-Xuan Cui, Hui-Lai Lv, Liang Chen, Bao-En Shan.   

Abstract

BACKGROUND/AIMS: Periplocin is extracted from the traditional herbal medicine cortex periplocae, which has been reported to suppress the growth of cancer cells. However, little is known about its effect on gastric cancer cells.
METHODS: Gastric cancer cells were treated with periplocin, and cell viability was assessed using MTS assay. Flow cytometry and TUNEL staining were performed to evaluate apoptosis, and protein expression was examined by western blotting. Microarray analysis was used to screen for changes in related genes.
RESULTS: We found that periplocin had an inhibitory effect on gastric cancer cell viability in a dose-dependent manner. Periplocin inhibited cell viability via the ERK1/2-EGR1 pathway to induce apoptosis. Periplocin also inhibited the growth of tumor xenografts and induced apoptosis in vivo.
CONCLUSION: Our results show that periplocin inhibits the proliferation of gastric cancer cells and induces apoptosis in vitro and in vivo, indicating its potential to be used as an antitumor drug.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27160973     DOI: 10.1159/000445555

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  13 in total

1.  Egr1 deficiency disrupts dynamic equilibrium of chondrocyte extracellular matrix through PPARγ/RUNX2 signaling pathways.

Authors:  Ke Lu; Tian-Shu Shi; Si-Yu Shen; Wan-Li Lu; Jing Wu; Kai-Jia Zhang; Xiao-Bo Zhu; Yong Shi; Xiang-Lin Liu; Fei Yu; Lan Li; Hua-Jian Teng; Xiang Gao; Huang-Xian Ju; Wei Wang; Chao-Jun Li; Qing Jiang; Bin Xue
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

2.  Bioinformatics analysis to identify action targets in NCI-N87 gastric cancer cells exposed to quercetin.

Authors:  Yun Zeng; Zhengjie Shen; Wenzhe Gu; Mianhua Wu
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

3.  Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively.

Authors:  Chao Tang; Ruixin Sun; Guodao Wen; Chunyu Zhong; Jin Yang; Junhao Zhu; Zixiang Cong; Xiaoying Luo; Chiyuan Ma
Journal:  Cell Death Dis       Date:  2019-04-18       Impact factor: 8.469

4.  Correlation between Quality and Geographical Origins of Cortex Periplocae, Based on the Qualitative and Quantitative Determination of Chemical Markers Combined with Chemical Pattern Recognition.

Authors:  Mengyuan Gao; Xiaohua Jia; Xuhua Huang; Wei Wang; Guangzhe Yao; Yanxu Chang; Huizi Ouyang; Tianxiang Li; Jun He
Journal:  Molecules       Date:  2019-10-08       Impact factor: 4.411

5.  Intermedin facilitates hepatocellular carcinoma cell survival and invasion via ERK1/2-EGR1/DDIT3 signaling cascade.

Authors:  Fei Xiao; Hongyu Li; Zhongxue Feng; Luping Huang; Lingmiao Kong; Min Li; Denian Wang; Fei Liu; Zhijun Zhu; Yong'gang Wei; Wei Zhang
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

6.  Periplocin inhibits the growth of pancreatic cancer by inducing apoptosis via AMPK-mTOR signaling.

Authors:  Gangyin Xie; Linxiao Sun; Yonglin Li; Bicheng Chen; Cheng Wang
Journal:  Cancer Med       Date:  2020-11-24       Impact factor: 4.452

7.  Pathways involved in pony body size development.

Authors:  Jun Fang; Dong Zhang; Jun Wei Cao; Li Zhang; Chun Xia Liu; Yan Ping Xing; Feng Wang; Hong Yang Xu; Shi Chao Wang; Yu Ling; Wei Wang; Yan Ru Zhang; Huan Min Zhou
Journal:  BMC Genomics       Date:  2021-01-18       Impact factor: 3.969

8.  Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter.

Authors:  Dian-Gang Chen; Bo Zhu; Sheng-Qing Lv; Hongfan Zhu; Jinliang Tang; Changlin Huang; Qingrui Li; Pu Zhou; Dong-Lin Wang; Guang-Hui Li
Journal:  J Exp Clin Cancer Res       Date:  2017-12-15

9.  Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c-MYC axis in breast cancer.

Authors:  Yan Liu; Hang Song; Shiyi Yu; Kuo-Hsiang Huang; Xinxing Ma; Yehui Zhou; Shuang Yu; Jingzhong Zhang; Liming Chen
Journal:  J Cell Mol Med       Date:  2020-01-16       Impact factor: 5.310

10.  Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy.

Authors:  Lujuan Han; Suli Dai; Zhirong Li; Cong Zhang; Sisi Wei; Ruinian Zhao; Hongtao Zhang; Lianmei Zhao; Baoen Shan
Journal:  J Exp Clin Cancer Res       Date:  2019-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.